Published in PLoS Pathog on September 05, 2008
Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol (2009) 2.33
Virus cell-to-cell transmission. J Virol (2010) 1.84
Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol (2011) 1.77
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J (2009) 1.75
Current understanding of the mechanism of HPV infection. Gynecol Oncol (2010) 1.74
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol (2010) 1.67
RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog (2009) 1.65
Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A (2013) 1.47
Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J (2009) 1.36
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One (2009) 1.25
The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol (2013) 1.20
Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog (2009) 1.17
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog (2014) 1.16
A role for heparan sulfate in viral surfing. Biochem Biophys Res Commun (2009) 1.15
Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol (2013) 1.11
Directional spread of surface-associated retroviruses regulated by differential virus-cell interactions. J Virol (2010) 1.09
Filopodial retraction force is generated by cortical actin dynamics and controlled by reversible tethering at the tip. Proc Natl Acad Sci U S A (2013) 1.08
Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology (2010) 1.08
The role of furin in papillomavirus infection. Future Microbiol (2009) 1.06
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol (2010) 1.03
Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol (2012) 1.03
Endocytosis of viruses and bacteria. Cold Spring Harb Perspect Biol (2014) 1.02
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol (2013) 1.01
Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking. J Virol (2009) 1.01
Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol (2013) 1.00
Alphaherpesviruses and the cytoskeleton in neuronal infections. Viruses (2011) 0.98
Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues. Mol Ther (2011) 0.94
Concepts of papillomavirus entry into host cells. Curr Opin Virol (2013) 0.93
The actin cytoskeleton has an active role in the electrotransfer of plasmid DNA in mammalian cells. Mol Ther (2011) 0.92
Rapid actin-dependent viral motility in live cells. Biophys J (2009) 0.92
Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission. J Virol (2014) 0.92
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell Microbiol (2012) 0.90
Live cell imaging of viral entry. Curr Opin Virol (2013) 0.90
Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner. J Virol (2014) 0.89
Filopodium retraction is controlled by adhesion to its tip. J Cell Sci (2012) 0.89
Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J Virol (2013) 0.87
Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells. J Virol (2015) 0.85
Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses. Bioorg Med Chem (2014) 0.85
[HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development]. Pathologe (2011) 0.83
Multiscale perspectives of virus entry via endocytosis. Virol J (2013) 0.83
Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types. J Gen Virol (2009) 0.82
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate. Virology (2014) 0.82
Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry. J Virol (2014) 0.81
Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry. PLoS One (2013) 0.80
Viral exploitation of actin: force-generation and scaffolding functions in viral infection. Virol Sin (2014) 0.80
Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis. Viruses (2015) 0.79
Filopodia and Viruses: An Analysis of Membrane Processes in Entry Mechanisms. Front Microbiol (2016) 0.78
Influenza entry pathways in polarized MDCK cells. Biochem Biophys Res Commun (2014) 0.78
The cytoskeleton in papillomavirus infection. Viruses (2011) 0.78
Rho'ing in and out of cells: viral interactions with Rho GTPase signaling. Small GTPases (2014) 0.78
A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16. J Virol (2015) 0.77
Notable Aspects of Glycan-Protein Interactions. Biomolecules (2015) 0.77
Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse. ACS Nano (2015) 0.77
Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus. Virus Res (2016) 0.76
Real-time Imaging of Rabies Virus Entry into Living Vero cells. Sci Rep (2015) 0.76
Viral infection: Moving through complex and dynamic cell-membrane structures. Commun Integr Biol (2011) 0.76
The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis. J Virol (2016) 0.75
Motion analysis of live objects by super-resolution fluorescence microscopy. Comput Math Methods Med (2011) 0.75
HPV disease transmission protection and control. Microb Cell (2016) 0.75
Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction. Hum Gene Ther (2016) 0.75
Anal warts and anal intradermal neoplasia. Clin Colon Rectal Surg (2011) 0.75
Rab5 and Rab11 are required for clathrin-dependent endocytosis of Japanese encephalitis virus in BHK-21 cells. J Virol (2017) 0.75
Vimentin modulates infectious internalisation of HPV16 pseudovirions. J Virol (2017) 0.75
A photoactivatable GFP for selective photolabeling of proteins and cells. Science (2002) 12.02
Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell (1997) 10.22
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93
Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell (2000) 8.13
Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules. Annu Rev Biophys Biomol Struct (2005) 6.99
Feature point tracking and trajectory analysis for video imaging in cell biology. J Struct Biol (2005) 6.49
Virus entry: open sesame. Cell (2006) 6.33
Fluorescent speckle microscopy, a method to visualize the dynamics of protein assemblies in living cells. Curr Biol (1998) 5.69
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science (2008) 5.04
Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol (2004) 4.85
Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol (1992) 4.37
Myosin II functions in actin-bundle turnover in neuronal growth cones. Nat Cell Biol (2006) 3.91
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med (2007) 3.88
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
Myosin drives retrograde F-actin flow in neuronal growth cones. Neuron (1996) 3.33
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med (2005) 3.26
Maturation of papillomavirus capsids. J Virol (2005) 3.18
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Growth cone advance is inversely proportional to retrograde F-actin flow. Neuron (1995) 3.09
Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol (1989) 3.06
Gangliosides are receptors for murine polyoma virus and SV40. EMBO J (2003) 2.99
Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol (2005) 2.95
Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J Cell Biol (2005) 2.83
The Ig superfamily cell adhesion molecule, apCAM, mediates growth cone steering by substrate-cytoskeletal coupling. J Cell Biol (1998) 2.66
Actin dynamics in vivo. Curr Opin Cell Biol (1997) 2.58
Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell (2007) 2.57
Filopodia are required for cortical neurite initiation. Nat Cell Biol (2007) 2.49
Papillomaviruses infect cells via a clathrin-dependent pathway. Virology (2003) 2.47
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
Reaching out for signals: filopodia sense EGF and respond by directed retrograde transport of activated receptors. J Cell Biol (2005) 2.26
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol (2008) 2.22
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol (2007) 2.05
Syndecans: multifunctional cell-surface co-receptors. Biochem J (1997) 2.04
Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol (2003) 2.02
Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc Natl Acad Sci U S A (2005) 2.01
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol (2007) 1.96
Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol (2003) 1.82
Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology (2005) 1.73
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 1.70
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67
Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67
Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol (2007) 1.59
Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol (1996) 1.32
Glypicans. Int J Biochem Cell Biol (2003) 1.25
Characterization of fluorescein-oligonucleotide conjugates and measurement of local electrostatic potential. Biopolymers (1998) 1.24
Ganglioside-dependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett (2003) 1.20
Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett (2001) 1.19
Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol (2003) 9.85
Virus entry: open sesame. Cell (2006) 6.33
Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (2002) 5.41
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
Endosome maturation. EMBO J (2011) 5.22
Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science (2008) 5.04
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA (2007) 4.66
How viruses enter animal cells. Science (2004) 4.35
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst (2011) 3.92
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med (2007) 3.88
Virus entry by macropinocytosis. Nat Cell Biol (2009) 3.87
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology (2004) 3.85
Virus entry by endocytosis. Annu Rev Biochem (2010) 3.74
Endocytosis via caveolae. Traffic (2002) 3.41
Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell (2004) 3.30
Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med (2005) 3.26
Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol (2005) 3.26
Maturation of papillomavirus capsids. J Virol (2005) 3.18
Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol (2005) 2.95
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol (2011) 2.85
Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol (2003) 2.80
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov (2011) 2.66
Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A (2006) 2.64
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst (2003) 2.58
Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell (2007) 2.57
Papillomaviruses infect cells via a clathrin-dependent pathway. Virology (2003) 2.47
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A (2004) 2.43
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol (2008) 2.37
Prophylactic human papillomavirus vaccines. J Clin Invest (2006) 2.36
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology (2005) 2.31
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25
In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe (2010) 2.24
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol (2008) 2.22
Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J Cell Biol (2005) 2.19
Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prev Res (Phila) (2013) 2.17
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
DC-SIGN as a receptor for phleboviruses. Cell Host Microbe (2011) 2.15
Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol (2012) 2.13
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol (2007) 2.05
A simple, versatile method for GFP-based super-resolution microscopy via nanobodies. Nat Methods (2012) 2.04
GM1 structure determines SV40-induced membrane invagination and infection. Nat Cell Biol (2009) 2.04
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One (2013) 2.03
Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc Natl Acad Sci U S A (2005) 2.01
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A (2008) 2.00
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst (2009) 1.95
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol (2002) 1.95
Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A (2003) 1.93
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine (2011) 1.91
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A (2009) 1.90
Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J Cell Biol (2010) 1.83
Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol (2008) 1.83
Effects of organelle shape on fluorescence recovery after photobleaching. Biophys J (2005) 1.77
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Current understanding of the mechanism of HPV infection. Gynecol Oncol (2010) 1.74
Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol (2008) 1.73
Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J Natl Cancer Inst (2011) 1.71
TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc Natl Acad Sci U S A (2002) 1.70
Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol (2003) 1.68
Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol Cell (2004) 1.62
Ankyrin-dependent and -independent mechanisms orchestrate axonal compartmentalization of L1 family members neurofascin and L1/neuron-glia cell adhesion molecule. J Neurosci (2007) 1.60
N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J Virol (2007) 1.59
Simulations of (an)isotropic diffusion on curved biological surfaces. Biophys J (2005) 1.57
ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem (2004) 1.55
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55
High-speed nanoscopic tracking of the position and orientation of a single virus. Nat Methods (2009) 1.55
Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A (2013) 1.51
Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic (2009) 1.50
Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol (2009) 1.49
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol (2002) 1.48
Binding-activated localization microscopy of DNA structures. Nano Lett (2011) 1.48
Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer (2008) 1.46
Role of endosomes in simian virus 40 entry and infection. J Virol (2011) 1.46
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell (2004) 1.45
More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol Cell (2005) 1.45
BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nat Cell Biol (2011) 1.45
Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc Natl Acad Sci U S A (2010) 1.45
RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep (2012) 1.40
Entry of bunyaviruses into mammalian cells. Cell Host Microbe (2010) 1.40
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J Infect Dis (2003) 1.40
Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.38
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest (2012) 1.37
Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog (2013) 1.35
Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine (2010) 1.33
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection. J Virol (2011) 1.32
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29